Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

TP53 bound to EP300 increases the amount of TP53. 2 / 2

| 2

➶

reach

"In contrast, MCF-7 cell treatment with TNF-alpha led to dissociation of the HDAC3-ERalpha complex and substitution of the occupancy on the promoter by the p53-p300 complex, thus accelerating p53 target gene expression."

32455774

➶

reach

"In contrast, MCF-7 cell treatment with TNF-alpha led to dissociation of the HDAC3 and ERalpha complex and substitution of the occupancy on the promoter by the p53 and p300 complex, thus accelerating p53 target gene expression."

32455774

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...